id	sid	eid	entity	type
dpc-5320	3	1	1	CARDINAL
dpc-5320	3	2	two	CARDINAL
dpc-5320	3	3	fernando caballero-linares1	PERSON
dpc-5320	3	4	bianca cei2	ORG
dpc-5320	3	5	fernando alfageme1	PERSON
dpc-5320	3	6	1	CARDINAL
dpc-5320	3	7	universitario puerta de hierro majadahonda	PERSON
dpc-5320	3	8	madrid	GPE
dpc-5320	3	9	spain	GPE
dpc-5320	3	10	2	CARDINAL
dpc-5320	3	11	university of pisa	ORG
dpc-5320	3	12	italy	GPE
dpc-5320	3	13	adalimumab	ORG
dpc-5320	3	14	bianca c	ORG
dpc-5320	3	15	alfageme f. hepatotoxicity	PERSON
dpc-5320	3	16	adalimumab	ORG
dpc-5320	3	17	two	CARDINAL
dpc-5320	5	1	2025;15(3):5320	CARDINAL
dpc-5320	6	1	january 27, 2025	DATE
dpc-5320	6	2	july 2025	DATE
dpc-5320	7	1	2025	CARDINAL
dpc-5320	8	1	https://creativecommons.org/licenses/by-nc/4.0/	ORG
dpc-5320	12	1	fernando caballero-linares	PERSON
dpc-5320	12	2	md	GPE
dpc-5320	12	3	universitario puerta de hierro majadahonda	PERSON
dpc-5320	12	4	calle joaquín rodrigo	PERSON
dpc-5320	12	5	1, 28222	DATE
dpc-5320	12	6	majadahonda, madrid	ORG
dpc-5320	12	7	spain	GPE
dpc-5320	13	1	0009-0005-5652-7754	CARDINAL
dpc-5320	14	1	introduction adalimumab	PERSON
dpc-5320	16	1	two	CARDINAL
dpc-5320	16	2	hs	PERSON
dpc-5320	17	1	first	ORDINAL
dpc-5320	17	2	47-year-old	DATE
dpc-5320	17	3	hs hurley iii	PERSON
dpc-5320	17	4	2019	DATE
dpc-5320	18	1	two months	DATE
dpc-5320	19	1	80 mg	QUANTITY
dpc-5320	19	2	every two weeks	DATE
dpc-5320	20	1	2021	CARDINAL
dpc-5320	21	1	july 2024	DATE
dpc-5320	21	2	more than two years	DATE
dpc-5320	23	1	adalimumab	PERSON
dpc-5320	24	1	second	ORDINAL
dpc-5320	24	2	56-year-old	DATE
dpc-5320	24	3	eight	CARDINAL
dpc-5320	25	1	hs hurley iii	PERSON
dpc-5320	25	2	february 2022	DATE
dpc-5320	25	3	one month	DATE
dpc-5320	26	1	adalimumab	PERSON
dpc-5320	26	2	april 2022 2	DATE
dpc-5320	27	1	2025;15(3):5320	CARDINAL
dpc-5320	27	2	160 mg	QUANTITY
dpc-5320	28	1	just three days	DATE
dpc-5320	28	2	first	ORDINAL
dpc-5320	29	1	u/l	EVENT
dpc-5320	29	2	587	CARDINAL
dpc-5320	29	3	u/l	EVENT
dpc-5320	29	4	556	CARDINAL
dpc-5320	29	5	u/l	EVENT
dpc-5320	31	1	adalimumab	PERSON
dpc-5320	32	1	adalimumab	PERSON
dpc-5320	33	1	first	ORDINAL
dpc-5320	33	2	dili	GPE
dpc-5320	35	1	1	CARDINAL
dpc-5320	37	1	second	ORDINAL
dpc-5320	37	2	days	DATE
dpc-5320	39	1	2	CARDINAL
dpc-5320	40	1	3	CARDINAL
dpc-5320	41	1	two	CARDINAL
dpc-5320	42	1	adalimumab	PERSON
dpc-5320	45	1	1	CARDINAL
dpc-5320	45	2	bruno	PERSON
dpc-5320	45	3	amante m. drug-	PERSON
dpc-5320	45	4	adalimumab	PERSON
dpc-5320	47	1	2013;2013:406901	CARDINAL
dpc-5320	49	1	25431703	DATE
dpc-5320	50	1	2	CARDINAL
dpc-5320	50	2	kok	PERSON
dpc-5320	50	3	lester elw	PERSON
dpc-5320	50	4	lee wm	PERSON
dpc-5320	50	5	four	CARDINAL
dpc-5320	51	1	dis sci	PERSON
dpc-5320	52	1	2018;63(6):1654-1666	DATE
dpc-5320	54	1	29564668	CARDINAL
dpc-5320	55	1	3	CARDINAL
dpc-5320	55	2	french	NORP
dpc-5320	55	3	bonkovsky	PERSON
dpc-5320	56	1	anti-tnf	NORP
dpc-5320	58	1	2016;39(3):199-208	CARDINAL
dpc-5320	59	1	0150366-9	DATE
dpc-5320	60	1	26692395	DATE